Literature DB >> 25725967

How do revised shoulders that are culture positive for Propionibacterium differ from those that are not?

Clifford Hou1, Akash Gupta1, Michael Chen1, Frederick A Matsen2.   

Abstract

BACKGROUND: Many shoulder arthroplasties revised for pain, stiffness, or component loosening are culture positive for Propionibacterium. The culture results are unknown until days or weeks after surgery, too late to inform intraoperative surgical decisions and immediate postsurgical antibiotic treatment. The objective of this study was to identify preoperative and intraoperative characteristics that may alert surgeons to an increased likelihood of positive cultures.
METHODS: We analyzed the records of 132 shoulders that underwent surgical revision of a shoulder arthroplasty, 66 of which became culture positive for Propionibacterium and 66 did not.
RESULTS: Propionibacterium-positive and Propionibacterium-negative shoulders were similar with respect to many characteristics; however, Propionibacterium-negative shoulders were revised sooner after the index procedure and were significantly more likely to be female, to have sustained a fall, to have instability, and to have rotator cuff deficiency. Intraoperatively, Propionibacterium-positive shoulders demonstrated more glenoid erosions, glenoid osteolysis, glenoid loosening, and a higher incidence of a soft tissue membrane between the humeral component and humeral endosteum. Shoulders culture positive for Propionibacterium were more likely to be culture positive for another bacteria.
CONCLUSIONS: Although Propionibacterium-positive and Propionibacterium-negative shoulders have many similarities, factors such as male gender, delayed presentation, glenoid osteolysis and loosening, humeral membrane, and the absence of instability or cuff failure should arouse suspicion of Propionibacterium and suggest the need for deep cultures and consideration of aggressive surgical and medical treatment.
Copyright © 2015 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Propionibacterium; culture positive; shoulder arthroplasty

Mesh:

Year:  2015        PMID: 25725967     DOI: 10.1016/j.jse.2015.01.003

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  6 in total

1.  Bacterial DNA is associated with tunnel widening in failed ACL reconstructions.

Authors:  David C Flanigan; Joshua S Everhart; Alex C DiBartola; Devendra H Dusane; Moneer M Abouljoud; Robert A Magnussen; Christopher C Kaeding; Paul Stoodley
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-02-27       Impact factor: 4.342

Review 2.  Detritic synovitis can mimic a Propionibacterium periprosthetic infection.

Authors:  Jacob D Gorbaty; Robert M Lucas; Frederick A Matsen
Journal:  Int Orthop       Date:  2015-11-10       Impact factor: 3.075

Review 3.  Scoping review: Diagnosis and management of periprosthetic joint infection in shoulder arthroplasty.

Authors:  Anthony Egglestone; Helen Ingoe; Jonathan Rees; Michael Thomas; Richard Jeavons; Amar Rangan
Journal:  Shoulder Elbow       Date:  2018-07-25

4.  Survey of shoulder arthroplasty surgeons' methods for infection avoidance of Propionibacterium.

Authors:  Stephen A Parada; K Aaron Shaw; Josef K Eichinger; Monica J Stadecker; Laurence D Higgins; Jon J P Warner
Journal:  J Orthop       Date:  2018-02-02

5.  High rate of unexpected positive cultures in presumed aseptic revision of stiff shoulders after proximal humerus osteosynthesis.

Authors:  Doruk Akgün; Paulina-Maria Peters; Nina Maziak; Fabian Plachel; Marvin Minkus; Philipp Moroder
Journal:  BMC Musculoskelet Disord       Date:  2020-06-22       Impact factor: 2.362

6.  Incidence and predictors of positive intraoperative cultures in primary shoulder arthroplasty following prior ipsilateral shoulder surgery.

Authors:  Stephen Gates; Ivy Nguyen; Michael Del Core; Paul A Nakonezny; Hallie Bradley; Michael Khazzam
Journal:  JSES Int       Date:  2020-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.